Treace Medical Concepts, Inc. (TMCI) — 10-Q Filings
All 10-Q filings from Treace Medical Concepts, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Treace Medical Concepts Sees Revenue Growth Amidst Widening Quarterly Loss
— Nov 6, 2025 Risk: high
Treace Medical Concepts, Inc. (TMCI) reported revenue of $50.214 million for the three months ended September 30, 2025, an 11.4% increase from $45.086 million i -
Treace Medical Revenue Jumps 16.5%, But Net Loss Widens
— Aug 7, 2025 Risk: medium
Treace Medical Concepts, Inc. reported net revenue of $49.6 million for the three months ended June 30, 2025, a 15.6% increase from $42.9 million in the prior-y -
Treace Medical Concepts Q1 2025 10-Q Filed
— May 8, 2025 Risk: medium
Treace Medical Concepts, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including assets, liabilities, and -
Treace Medical Concepts Files Q3 2024 10-Q
— Nov 5, 2024 Risk: medium
Treace Medical Concepts, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the -
Treace Medical Concepts Files 10-Q
— Aug 6, 2024 Risk: medium
Treace Medical Concepts, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial position, including details on its revol -
Treace Medical Concepts, Inc. Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk: medium
TREACE MEDICAL CONCEPTS, INC. (TMCI) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Filed a 10-Q report for the period ending March 31, 2024. The
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX